4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUND

To provide novel compounds useful for treating neurological disorders including neurodegenerative disorders, especially neurological disorders characterized by the presence of oxidative stress, protein aggregation and intracellular or extracellular metal imbalance.SOLUTION: This invention relates to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JACK GORDON PARSONS, KEVIN JEFFREY BARNHAM, ELISABETH COLETTE LOUISE GAUTIER, PENELOPE JANE HUGGINS, ANTONY VINCENT ROBINSON
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To provide novel compounds useful for treating neurological disorders including neurodegenerative disorders, especially neurological disorders characterized by the presence of oxidative stress, protein aggregation and intracellular or extracellular metal imbalance.SOLUTION: This invention relates to compounds expressed by the following formula, and metal complex compounds comprising the compounds expressed by the following formula and a transition metal compound such as zinc and copper. (R2 is (CH2) nNR9R10; R9 and R10 are each independently H, a C1-C8 alkyl optionally interrupted with O, or the like; R5 is H or the like; R6 is H, a halogen or the like; provided that one of R5 and R6 is not H; R8 is H or the like; and n is 1, 2, or 3).SELECTED DRAWING: None 【課題】神経変性障害を含む神経障害、特に、酸化ストレス、タンパク質凝集、及び細胞内又は細胞外金属不均衡の存在を特徴とする神経障害の治療に有用な新規化合物の提供。【解決手段】下記式で表される化合物、及び、下記式で表される化合物と亜鉛、銅等の遷移金属化合物とからなる金属錯体化合物。(R2は(CH2)nNR9R10;R9及びR10は各々独立にH、Oによって場合により中断されたC1〜8アルキル等;R5はH等;R6は、H、ハロゲン等;ただし、R5およびR6のうちの1つがHではない;R8はH等;nは1、2又は3。)【選択図】なし